YOU ARE HERE >  Moneycontrol Markets > Announcements PharmaceuticalsAnnouncement - DIL
BSE: 506414NSE: ISIN: INE225B01013

6th-Feb-2017 09:44Source: BSE

DIL - Board Meeting Intimation for Results & Closure of Trading Window

Dil Ltd has informed BSE that meeting(s) of the Audit Committee and Board of Directors of the Company are scheduled to be held on February 13, 2017 inter alia, to consider and approve unaudited financial statements (Standalone and Consolidated) of the Company for the quarter ended December 31, 2016.

In compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company''s Code of Conduct to Regulate, Monitor and Report Trading by Insiders, it is hereby notified that "Trading Window"(period for trading in Companys securities) shall remain closed from Saturday, February 4, 2017 till thQ close of business hours on Wednesday, February 15, 2017 (both days inclusive) inter alia, for approval of the unaudited financial results (Standalone and Consolidated) of the Company, for the quarter ended December 31, 2016.

During the closure of Trading Window, all Directors, Promoters, Insiders, Designated Persons including Auditors shall not, directly or indirectly trade or deal or enter into any transaction involving sale or purchase of the Company''s Equity Shares, either in their own name or in the name of their Immediate Relatives.

Follow us on
Available On